Jon Christian Bates insider trades: Nutex Health (NUTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jon reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | NUTX | ↑ Buy | 750 | $136.71 | $103K | Direct | Nov 28, 2025 (3d) |
| Apr 8, 2025 | NUTX | ↑ Buy | 1,000 | $81.81 | $82K | Direct | Apr 14, 2025 (6d) |
| Aug 22, 2024 | NUTX | ↑ Buy | 1,350 | $21.46 | $29K | Direct | Aug 26, 2024 (4d) |
| Jun 15, 2023 | NUTX | ↑ Buy | 20,000 | $0.42 | $8K | Direct | Jun 20, 2023 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUTX insiders
Open-market trades in the last 12 months
About Jon Christian Bates's insider trades
Jon Christian Bates is Chief Financial Officer at Nutex Health (NUTX). Since Jun 15, 2023, Jon has reported 4 open-market purchases worth $222K and no sales on SEC Form 4. In the last 12 months: 1 buy ($103K).
Their filings also include option exercises (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.